 Dermatitis, Atopic
"Dermatitis, Atopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Descriptor ID |
D003876
|
| MeSH Number(s) |
C16.320.850.210 C17.800.174.193 C17.800.815.193 C17.800.827.210 C20.543.480.343
|
| Concept/Terms |
Dermatitis, Atopic- Dermatitis, Atopic
- Atopic Dermatitides
- Atopic Dermatitis
- Dermatitides, Atopic
- Neurodermatitis, Atopic
- Atopic Neurodermatitides
- Atopic Neurodermatitis
- Neurodermatitides, Atopic
- Neurodermatitis, Disseminated
- Disseminated Neurodermatitides
- Disseminated Neurodermatitis
- Neurodermatitides, Disseminated
- Eczema, Atopic
- Atopic Eczema
|
Below are MeSH descriptors whose meaning is more general than "Dermatitis, Atopic".
- Diseases [C]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Skin Diseases, Genetic [C16.320.850]
- Dermatitis, Atopic [C16.320.850.210]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Dermatitis [C17.800.174]
- Dermatitis, Atopic [C17.800.174.193]
- Skin Diseases, Eczematous [C17.800.815]
- Dermatitis, Atopic [C17.800.815.193]
- Skin Diseases, Genetic [C17.800.827]
- Dermatitis, Atopic [C17.800.827.210]
- Immune System Diseases [C20]
- Hypersensitivity [C20.543]
- Hypersensitivity, Immediate [C20.543.480]
- Dermatitis, Atopic [C20.543.480.343]
Below are MeSH descriptors whose meaning is more specific than "Dermatitis, Atopic".
This graph shows the total number of publications written about "Dermatitis, Atopic" by people in UAMS Profiles by year, and whether "Dermatitis, Atopic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 3 | 0 | 3 | | 2023 | 5 | 0 | 5 | | 2022 | 7 | 0 | 7 | | 2021 | 10 | 0 | 10 | | 2020 | 9 | 0 | 9 | | 2019 | 15 | 0 | 15 | | 2018 | 7 | 1 | 8 | | 2017 | 5 | 0 | 5 | | 2016 | 1 | 3 | 4 | | 2015 | 2 | 0 | 2 | | 2014 | 2 | 2 | 4 | | 2013 | 1 | 0 | 1 | | 2012 | 4 | 2 | 6 | | 2010 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dermatitis, Atopic" by people in Profiles over the past ten years.
-
Kline SN, Orlando NA, Lee AJ, Wu MJ, Zhang J, Youn C, Feller LE, Pontaza C, Dikeman D, Limjunyawong N, Williams KL, Wang Y, Cihakova D, Jacobsen EA, Durum SK, Garza LA, Dong X, Archer NK. Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation. Proc Natl Acad Sci U S A. 2024 Feb 06; 121(6):e2309243121.
-
Stein Gold LF, Tom WL, Shi V, Sanders P, Zang C, Vlahos B, Cha A. Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis. Dermatitis. 2024 Jan-Feb; 35(1):84-91.
-
Zengin HB, Tan PH, Liu R, Smoller BR. 'Eczematous' dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease. Pathology. 2024 Apr; 56(3):300-312.
-
Perry TT, Grant TL, Dantzer JA, Udemgba C, Jefferson AA. Impact of socioeconomic factors on allergic diseases. J Allergy Clin Immunol. 2024 Feb; 153(2):368-377.
-
Rajkumar J, Chandan N, Lio P, Shi V. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023; 36(4):174-185.
-
Shi VY, Chamberlain W, Siegfried E, Kraff-Cooper C, Beckman K, Lio P, Paller AS, Simpson E. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review. J Am Acad Dermatol. 2023 08; 89(2):309-315.
-
Lio P, Mackie D, Bates D, Mulvihill E, Patel M, Kim Y, Shi V. Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study. J Drugs Dermatol. 2023 Feb 01; 22(2):119-131.
-
Atluri K, Manne S, Nalamothu V, Mantel A, Sharma PK, Babu RJ. Advances in Current Drugs and Formulations for the Management of Atopic Dermatitis. Crit Rev Ther Drug Carrier Syst. 2023; 40(6):1-87.
-
Thompson AM, Seivright J, Hsiao JL, Shi VY. Bibliometric analysis of the 50 most cited publications in atopic dermatitis. Pediatr Dermatol. 2022 Jul; 39(4):578-583.
-
Rick JW, Morgan A, De DR, Hsiao JL, Shi VY. Allergens and marketing claims of the most popular baby moisturizers: A product analysis. J Am Acad Dermatol. 2023 01; 88(1):205-207.
-
Hwang J, Rick J, Hsiao J, Shi VY. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses. J Dermatolog Treat. 2022 Sep; 33(6):2711-2722.
-
Worm M, Thyssen JP, Schliemann S, Bauer A, Shi VY, Ehst B, Tillmann S, Korn S, Resen K, Agner T. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial. Br J Dermatol. 2022 07; 187(1):42-51.
-
Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358.
-
Sutaria N, Alphonse MP, Roh YS, Choi J, Parthasarathy V, Deng J, Bordeaux ZA, Taylor MT, Pritchard T, Kim N, Aguh C, Semenov YR, Archer NK, Garza LA, Kang S, Kwatra SG. Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis. J Invest Dermatol. 2022 09; 142(9):2537-2540.
-
Hwang J, Newton EM, Hsiao J, Shi VY. Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis. Exp Dermatol. 2022 04; 31(4):485-497.
-
Heckman CJ, Riley M, Niu Z, Lu SE, Valdes-Rodriguez R, Yosipovitch G. A single-arm pilot of a web-based intervention to improve itch-related quality of life. J Eur Acad Dermatol Venereol. 2022 Jan; 36(1):108-112.
-
Thompson AM, Hsiao JL, Shi VY. National Institutes of Health Funding Trends for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e94-e96.
-
Carnicle JM, Hendricks AJ, Shi VY. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e80-e82.
-
Ludwig CM, Hsiao JL, Lio PA, Shi VY. Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):S4-S7.
-
Modiri O, Yee D, Shi VY, Hsiao JL. Readability, Quality, and Timeliness of Online Health Resources for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e89-e91.
-
Hwang J, Thompson A, Jaros J, Blackcloud P, Hsiao J, Shi VY. Updated understanding of Staphylococcus aureus in atopic dermatitis: From virulence factors to commensals and clonal complexes. Exp Dermatol. 2021 10; 30(10):1532-1545.
-
Rick JW, Alavi A, Hsiao JL, Yosipovitch G, Shi VY. Atopic dermatitis and hidradenitis suppurativa: An under-recognized pair. J Am Acad Dermatol. 2021 12; 85(6):e387-e388.
-
Wongvibulsin S, Sutaria N, Kannan S, Alphonse MP, Belzberg M, Williams KA, Brown ID, Choi J, Roh YS, Pritchard T, Khanna R, Eseonu AC, Jedrych J, Dillen C, Kwatra MM, Chien AL, Archer N, Garza LA, Dong X, Kang S, Kwatra SG. Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation. Sci Rep. 2021 05 27; 11(1):11175.
-
Chandan N, Rajkumar JR, Shi VY, Lio PA. A new era of moisturizers. J Cosmet Dermatol. 2021 Aug; 20(8):2425-2430.
-
Patrick GJ, Liu H, Alphonse MP, Dikeman DA, Youn C, Otterson JC, Wang Y, Ravipati A, Mazhar M, Denny G, Ortines RV, Zhang E, Miller RJ, Dillen CA, Liu Q, Nolan SJ, Nguyen K, Marcello L, Do DC, Wier EM, Zhang Y, Caviness G, Klimowicz AC, Mierz DV, Fine JS, Sun G, Goldbach-Mansky R, Marusina AI, Merleev AA, Maverakis E, Garza LA, Milner JD, Gao P, Ramanujam M, Raymond EL, Archer NK, Miller LS. Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. J Clin Invest. 2021 03 01; 131(5).
-
Gurnee EA, Xu M, Risener CJ, Lehman K, Nelson K, Swerlick RA, Quave CL. Staphylococcal Hemolytic Potential Is Correlated with Increased Severity of Atopic Dermatitis in Children and Young Adults. J Invest Dermatol. 2021 06; 141(6):1588-1591.
-
Ludwig CM, Fernandez JM, Hsiao JL, Shi VY. The Interplay of Atopic Dermatitis and Sexual Health. Dermatitis. 2020 Sep/Oct; 31(5):303-308.
-
Sachdeva M, Price KN, Hsiao JL, Shi VY. Pearls for Managing Atopic Dermatitis in Patients With Low Socioeconomic Status. Dermatitis. 2020 Sep/Oct; 31(5):297-302.
-
Jaros J, Wilson C, Shi VY. Fabric Selection in Atopic Dermatitis: An Evidence-Based Review. Am J Clin Dermatol. 2020 Aug; 21(4):467-482.
-
Hwang J, Jaros J, Shi VY. Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future. Dermatitis. 2020 Jul/Aug; 31(4):247-258.
-
Shah M, Sachdeva M, Alavi A, Shi VY, Hsiao JL. Optimizing care for atopic dermatitis patients during the COVID-19 pandemic. J Am Acad Dermatol. 2020 08; 83(2):e165-e167.
-
Mochizuki H, Schut C, Shevchenko A, Valdes-Rodriguez R, Nattkemper LA, Yosipovitch G. A Negative Association of Hypothalamic Volume and Perceived Stress in Patients with Atopic Dermatitis. Acta Derm Venereol. 2020 May 11; 100(10):adv00129.
-
Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020 May-Jun; 31(3):169-177.
-
Capozza K, Gadd H, Kelley K, Russell S, Shi V, Schwartz A. Insights From Caregivers on the Impact of Pediatric Atopic Dermatitis on Families: "I'm Tired, Overwhelmed, and Feel Like I'm Failing as a Mother". Dermatitis. 2020 May/Jun; 31(3):223-227.
-
Ludwig CM, Krase JM, Price KN, Lio PA, Shi VY. A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):503-506.
-
Mata E, Loh TY, Ludwig C, Price KN, Fernandez JM, Krase JM, Shi VY. Pharmacy costs of systemic and topical medications for atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):514-516.
-
Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):19-28.
-
Yang EJ, Hendricks AJ, Beck KM, Shi VY. Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses. Dermatol Ther. 2019 11; 32(6):e13101.
-
Mollanazar NK, Qiu CC, Aldrich JL, Tedaldi E, Valdes-Rodriguez R, Savage KT, Hsu S. Use of dupilumab in patients who are HIV-positive: report of four cases. Br J Dermatol. 2019 12; 181(6):1311-1312.
-
Hendricks AJ, Manivannan M, Shi VY. Clinical Pearls on Sleep Management in Atopic Dermatitis. Dermatitis. 2019 Sep/Oct; 30(5):287-293.
-
Steele CE, Morrell D, Evans M. Metabolic syndrome and inflammatory skin conditions. Curr Opin Pediatr. 2019 08; 31(4):515-522.
-
Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569.
-
Hendricks AJ, Mills BW, Shi VY. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends. J Dermatol Sci. 2019 Aug; 95(2):56-61.
-
Heibel HD, Hendricks AJ, Foshee JP, Shi VY. Rosacea associated with dupilumab therapy. J Dermatolog Treat. 2021 Feb; 32(1):114-116.
-
Hendricks AJ, Shi VY. Learning About Dupilumab-Associated Conjunctivitis. JAMA Dermatol. 2019 06 01; 155(6):754.
-
Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019 May 15; 25(5).
-
Song PI, Armstrong CA. Novel therapeutic approach with PAC-14028 cream, a TRPV1 antagonist, for patients with mild-to-moderate atopic dermatitis. Br J Dermatol. 2019 05; 180(5):971-972.
-
Maarouf M, Hendricks AJ, Shi VY. Bathing Additives for Atopic Dermatitis - A Systematic Review. Dermatitis. 2019 May/Jun; 30(3):191-197.
-
Vaughn AR, Foolad N, Maarouf M, Tran KA, Shi VY. Micronutrients in Atopic Dermatitis: A Systematic Review. J Altern Complement Med. 2019 Jun; 25(6):567-577.
-
Costello C, Maarouf M, Shi V. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules J Drugs Dermatol. 2018 12 01; 17(12):1330-1332.
-
LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol. 2019 Jan; 36(1):36-65.
-
Archer NK, Jo JH, Lee SK, Kim D, Smith B, Ortines RV, Wang Y, Marchitto MC, Ravipati A, Cai SS, Dillen CA, Liu H, Miller RJ, Ashbaugh AG, Uppal AS, Oyoshi MK, Malhotra N, Hoff S, Garza LA, Kong HH, Segre JA, Geha RS, Miller LS. Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1a release. J Allergy Clin Immunol. 2019 04; 143(4):1426-1443.e6.
-
Maarouf M, Kromenacker B, Capozza KL, Kempton D, Hendricks A, Tran K, Shi VY. Pain and Itch Are Dual Burdens in Atopic Dermatitis. Dermatitis. 2018 Sep/Oct; 29(5):278-281.
-
Maarouf M, Saberian C, Lio PA, Shi VY. Head-and-neck dermatitis: Diagnostic difficulties and management pearls. Pediatr Dermatol. 2018 Nov; 35(6):748-753.
-
Grossman SK, Schut C, Kupfer J, Valdes-Rodriguez R, Gieler U, Yosipovitch G. Experiences with the first eczema school in the United States. Clin Dermatol. 2018 Sep - Oct; 36(5):662-667.
-
Maarouf M, Shi VY. Bleach for Atopic Dermatitis. Dermatitis. 2018 May/Jun; 29(3):120-126.
-
Nattkemper LA, Tey HL, Valdes-Rodriguez R, Lee H, Mollanazar NK, Albornoz C, Sanders KM, Yosipovitch G. The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe?Itch. J Invest Dermatol. 2018 06; 138(6):1311-1317.
-
Vaughn AR, Clark AK, Sivamani RK, Shi VY. Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy. Pediatr Dermatol. 2018 Jan; 35(1):152-157.
-
Hendricks AJ, Vaughn AR, Clark AK, Yosipovitch G, Shi VY. Sweat mechanisms and dysfunctions in atopic dermatitis. J Dermatol Sci. 2018 Feb; 89(2):105-111.
-
Lee DE, Clark AK, Tran KA, Shi VY. New and emerging targeted systemic therapies: a new era for atopic dermatitis. J Dermatolog Treat. 2018 Jun; 29(4):364-374.
-
Vaughn AR, Sivamani RK, Lio PA, Shi VY. Paternal vs. Maternal Factors in Childhood Atopic Dermatitis. Dermatitis. 2017 Jul-Aug; 28(4):241-245.
-
Gochnauer H, Valdes-Rodriguez R, Cardwell L, Anolik RB. The Psychosocial Impact of Atopic Dermatitis. Adv Exp Med Biol. 2017; 1027:57-69.
-
Kim KH, Blasco-Morente G, Cuende N, Arias-Santiago S. Mesenchymal stromal cells: properties and role in management of cutaneous diseases. J Eur Acad Dermatol Venereol. 2017 Mar; 31(3):414-423.
-
Bunyavanich S, Shen N, Grishin A, Wood R, Burks W, Dawson P, Jones SM, Leung DYM, Sampson H, Sicherer S, Clemente JC. Early-life gut microbiome composition and milk allergy resolution. J Allergy Clin Immunol. 2016 10; 138(4):1122-1130.
-
Bagherani N, Smoller BR. Effectiveness of azathioprine pulse therapy in prolonging remission of psoriasis. Dermatol Ther. 2017 01; 30(1).
-
Chawla V, Hogan MB, Moonie S, Fenwick GL, Hooft A, Wilson NW. Parental perception of efficacy of antihistamines for pruritus in pediatric atopic dermatitis. Allergy Asthma Proc. 2016 Mar-Apr; 37(2):157-63.
-
Shi VY, Leo M, Hassoun L, Chahal DS, Maibach HI, Sivamani RK. Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol. 2015 Nov; 73(5):856-63.
-
Nattkemper LA, Lee HG, Valdes-Rodriguez R, Mollanazar NK, Sanders KM, Yosipovitch G. Cholinergic induction of perspiration attenuates nonhistaminergic pruritus in the skin of patients with atopic dermatitis and healthy controls. Br J Dermatol. 2015 Jul; 173(1):282-4.
-
Bao L, Alexander JB, Shi VY, Mohan GC, Chan LS. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites. Immunology. 2014 Dec; 143(4):601-8.
-
Brough HA, Liu AH, Sicherer S, Makinson K, Douiri A, Brown SJ, Stephens AC, Irwin McLean WH, Turcanu V, Wood RA, Jones SM, Burks W, Dawson P, Stablein D, Sampson H, Lack G. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol. 2015 Jan; 135(1):164-70.
-
Shi VY, Joo JS, Sharon VR. Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors. Dermatol Online J. 2014 Aug 17; 20(8).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|